161 related articles for article (PubMed ID: 3159462)
1. Quinolinic acid phosphoribosyltransferase in human and rat brain: activity in Huntington's disease and in quinolinate-lesioned rat striatum.
Foster AC; Whetsell WO; Bird ED; Schwarcz R
Brain Res; 1985 Jun; 336(2):207-14. PubMed ID: 3159462
[TBL] [Abstract][Full Text] [Related]
2. gamma-Glutamyltransferase activity is unchanged in acutely quinolinate-lesioned rat neostriatum but is elevated in Huntington's disease caudate.
Zhu SG; McGeer EG; McGeer PL
Exp Neurol; 1990 Jan; 107(1):106-9. PubMed ID: 1967236
[TBL] [Abstract][Full Text] [Related]
3. Basal ganglia lesions in the rat: effects on quinolinic acid metabolism.
Schwarcz R; Okuno E; White RJ
Brain Res; 1989 Jun; 490(1):103-9. PubMed ID: 2527078
[TBL] [Abstract][Full Text] [Related]
4. Characterization of quinolinic acid phosphoribosyltransferase in human blood and observations in Huntington's disease.
Foster AC; Schwarcz R
J Neurochem; 1985 Jul; 45(1):199-205. PubMed ID: 2582090
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracerebral injections of quinolinic acid on serotonergic neurons in the rat brain.
Aldinio C; Mazzari S; Toffano G; Köhler C; Schwarcz R
Brain Res; 1985 Aug; 341(1):57-65. PubMed ID: 2412634
[TBL] [Abstract][Full Text] [Related]
6. Neural grafting in a rat model of Huntington's disease: progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting.
Isacson O; Brundin P; Gage FH; Björklund A
Neuroscience; 1985 Dec; 16(4):799-817. PubMed ID: 2936982
[TBL] [Abstract][Full Text] [Related]
7. Increased quinolinic acid metabolism following neuronal degeneration in the rat hippocampus.
Speciale C; Okuno E; Schwarcz R
Brain Res; 1987 Dec; 436(1):18-24. PubMed ID: 2961415
[TBL] [Abstract][Full Text] [Related]
8. Systemic treatments with GM1 ganglioside reduce quinolinic acid-induced striatal lesions in the rat.
Lombardi G; Zanoni R; Moroni F
Eur J Pharmacol; 1989 Dec; 174(1):123-5. PubMed ID: 2612575
[TBL] [Abstract][Full Text] [Related]
9. Quinolinic acid metabolism in the rat brain. Immunohistochemical identification of 3-hydroxyanthranilic acid oxygenase and quinolinic acid phosphoribosyltransferase in the hippocampal region.
Köhler C; Eriksson LG; Flood PR; Hardie JA; Okuno E; Schwarcz R
J Neurosci; 1988 Mar; 8(3):975-87. PubMed ID: 3346732
[TBL] [Abstract][Full Text] [Related]
10. Elevation of Met-enkephalin-like immunoreactivity in the rat striatum and globus pallidus following the focal injection of excitotoxins.
Ruzicka BB; Jhamandas K
Brain Res; 1990 Dec; 536(1-2):227-39. PubMed ID: 2150770
[TBL] [Abstract][Full Text] [Related]
11. Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease.
Heyes MP; Swartz KJ; Markey SP; Beal MF
Neurosci Lett; 1991 Jan; 122(2):265-9. PubMed ID: 1827518
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of quinolinic acid phosphoribosyltransferase in the human neostriatum.
Du F; Okuno E; Whetsell WO; Köhler C; Schwarcz R
Neuroscience; 1991; 42(2):397-406. PubMed ID: 1832752
[TBL] [Abstract][Full Text] [Related]
13. Intracerebral quinolinic acid injection in the rat: effects on dopaminergic neurons.
Mazzari S; Aldinio C; Beccaro M; Toffano G; Schwarcz R
Brain Res; 1986 Aug; 380(2):309-16. PubMed ID: 2944562
[TBL] [Abstract][Full Text] [Related]
14. Quinolinic acid elevates striatal and pallidal Met-enkephalin levels: the role of enkephalin synthesis and release.
Ruzicka BB; Day R; Jhamandas K
Brain Res; 1991 Oct; 562(1):117-25. PubMed ID: 1839239
[TBL] [Abstract][Full Text] [Related]
15. The neurotoxic actions of quinolinic acid in the central nervous system.
el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ
Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936
[TBL] [Abstract][Full Text] [Related]
16. Quinolinic acid phosphoribosyltransferase in rat brain.
Foster AC; Zinkand WC; Schwarcz R
J Neurochem; 1985 Feb; 44(2):446-54. PubMed ID: 2578178
[TBL] [Abstract][Full Text] [Related]
17. Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system.
Whetsell WO; Schwarcz R
Neurosci Lett; 1989 Feb; 97(3):271-5. PubMed ID: 2524015
[TBL] [Abstract][Full Text] [Related]
18. Reduced GABA transaminase activity in the Huntington's disease putamen.
Carter CJ
Neurosci Lett; 1984 Aug; 48(3):339-42. PubMed ID: 6237280
[TBL] [Abstract][Full Text] [Related]
19. Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat.
Foster AC; Miller LP; Oldendorf WH; Schwarcz R
Exp Neurol; 1984 May; 84(2):428-40. PubMed ID: 6232146
[TBL] [Abstract][Full Text] [Related]
20. Amino acid neurotransmitter abnormalities in Huntington's disease and the quinolinic acid animal model of Huntington's disease.
Ellison DW; Beal MF; Mazurek MF; Malloy JR; Bird ED; Martin JB
Brain; 1987 Dec; 110 ( Pt 6)():1657-73. PubMed ID: 2892568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
